Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Atara Biotherapeutics (ATRA) just unveiled an announcement.
Eric Dobmeier, a board member of Atara Biotherapeutics, Inc., has decided not to seek re-election at the forthcoming 2024 Annual Meeting, though he will complete his current term. His departure is not due to any conflict with the company’s management or board regarding its operations, policies, or practices.
For an in-depth examination of ATRA stock, go to TipRanks’ Stock Analysis page.